153 related articles for article (PubMed ID: 37313861)
1. Infantile spasms caused by
Zhong L; Liu C; Lin L
Appl Neuropsychol Child; 2023; 12(4):380-385. PubMed ID: 37313861
[TBL] [Abstract][Full Text] [Related]
2. Treatment of infantile spasms.
Hancock E; Osborne J; Milner P
Cochrane Database Syst Rev; 2003; (3):CD001770. PubMed ID: 12917912
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
Ibrahim S; Gulab S; Ishaque S; Saleem T
BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
[TBL] [Abstract][Full Text] [Related]
5. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
[TBL] [Abstract][Full Text] [Related]
6. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
Iyer A; Appleton R
Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
[TBL] [Abstract][Full Text] [Related]
7. Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy.
Sakpichaisakul K; Boonkrongsak R; Lertbutsayanukul P; Iemwimangsa N; Klumsathian S; Panthan B; Trachoo O
BMC Neurol; 2022 Dec; 22(1):461. PubMed ID: 36494631
[TBL] [Abstract][Full Text] [Related]
8. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
Yum MS; Lee EH; Ko TS
J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
[TBL] [Abstract][Full Text] [Related]
9.
Chen S; Deng X; Xiong J; Chen B; He F; Yang L; Yang L; Peng J; Yin F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):265-270. PubMed ID: 35545418
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin in the treatment of infantile spasms in tuberous sclerosis: literature review.
Hancock E; Osborne JP
J Child Neurol; 1999 Feb; 14(2):71-4. PubMed ID: 10073425
[TBL] [Abstract][Full Text] [Related]
11. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
[TBL] [Abstract][Full Text] [Related]
12. Treatment of infantile spasms.
Hancock E; Osborne JP; Milner P
Cochrane Database Syst Rev; 2002; (2):CD001770. PubMed ID: 12076419
[TBL] [Abstract][Full Text] [Related]
13. Treatment of infantile spasms with sodium valproate followed by benzodiazepines.
Auvichayapat N; Tassniyom S; Treerotphon S; Auvichayapat P
J Med Assoc Thai; 2007 Sep; 90(9):1809-14. PubMed ID: 17957923
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in children with infantile spasms treated with vigabatrin: a cohort of 180 patients.
Djuric M; Kravljanac R; Tadic B; Mrlješ-Popovic N; Appleton RE
Epilepsia; 2014 Dec; 55(12):1918-25. PubMed ID: 25377998
[TBL] [Abstract][Full Text] [Related]
15. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
[TBL] [Abstract][Full Text] [Related]
16. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
18. A risk-benefit assessment of treatments for infantile spasms.
Nabbout R
Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
[TBL] [Abstract][Full Text] [Related]
19. Treatment of infantile spasms.
Hancock EC; Osborne JP; Edwards SW
Cochrane Database Syst Rev; 2008 Oct; (4):CD001770. PubMed ID: 18843624
[TBL] [Abstract][Full Text] [Related]
20. Brain MRI findings with vigabatrin therapy: case report and literature review.
Hussain K; Walsh TJ; Chazen JL
Clin Imaging; 2016; 40(1):180-2. PubMed ID: 26526789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
